Abstract:Introduction: Efficient delivery of therapeutics across the blood-brain barrier (BBB) for the treatment of central nervous system (CNS) tumors is a major challenge to the development of safe and efficacious therapies. Locoregional drug delivery platforms offer an improved therapeutic index by achieving high drug concentrations in the target tissue with negligible systemic exposure. Intrathecal (intraventricular) [IT] and convection-enhanced delivery [CED] are two clinically relevant methods being employed for various CNS malignancies. Both of these standalone platforms suffer from passive post-administration distribution forces, sometimes limiting the desired distribution for tumor therapy. Focused ultrasound and microbubble-mediated blood-brain barrier opening (FUS-BBBO) is a recent modality used for enhanced drug delivery. It is postulated that coupling of FUS with these alternative delivery routes may provide benefits. Multimodality FUS may provide the desired ability to increase the depth of parenchymal delivery following IT administration and provide a means for contour directionality with CED. Further, the transient enhanced permeability achieved with FUS-BBBO is well established, but drug residence and transit times, important to clinical dose scheduling, have not yet been defined. The present investigation comprises two discrete studies: 1. Conduct a comprehensive quantitative evaluation to elucidate the effect of FUS-BBBO as it relates to varying routes of administration (IT and IV) in its capacity to facilitate drug penetration within the striatal-thalamic region. 2. Investigate the impact of combining FUS-BBBO with CED on drug distribution, with a specific focus on the temporal dynamics of drug retention within the target region. Methods: Firstly, we quantitatively assessed how FUS-BBBO coupled with IT and IV altered fluorescent dye (Dextran 2000 kDa and 70 kDa) distribution and concentration in a predetermined striatal-thalamic region in naïve mice. Secondly, we analyzed the pharmacokinetic effects of using FUS mediated BBB disruption coupled with CED by measuring the volume of distribution and time-dependent concentration of the dye. Results: Our results indicate that IV administration coupled with FUS-BBBO successfully enhances delivery of dye into the pre-defined sonication targets. Conversely, measurable dye in the sonication target was consistently less after IT administration. FUS enhances the distribution volume of dye after CED. Furthermore, a shorter time of residence was observed when CED was coupled with FUS-BBBO application when compared to CED alone. Conclusion: 1. Based on our findings, IV delivery coupled with FUS-BBBO is a more efficient means for delivery to deep targets (i.e. striatal-thalamic region) within a predefined spatial conformation compared to IT administration. 2. FUS-BBBO increases the volume of distribution (Vd) of dye after CED administration, but results in a shorter time of residence. Whether this finding is reproducible with other classes of agents (e.g., cytotoxic agents, antibodies, viral particles, cellular therapies) needs to be studied.

Targeted drug delivery across the blood-brain barrier using ultrasound technique.

Facilitation of Drug Transport across the Blood-Brain Barrier with Ultrasound and Microbubbles

Current clinical investigations of focused ultrasound blood-brain barrier disruption: A review

Current Progress in Magnetic Resonance-Guided Focused Ultrasound to Facilitate Drug Delivery across the Blood-Brain Barrier

Ultrasound-mediated drug delivery to the brain: principles, progress and prospects

Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor

Theranostic Strategy of Focused Ultrasound Induced Blood-Brain Barrier Opening for CNS Disease Treatment

Focused Ultrasound Combined with Microbubbles in Central Nervous System Applications

Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases

Applications of focused ultrasound-mediated blood-brain barrier opening

Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system

Chapter Five - Precision medicine focus on the central nervous system: Non-invasive therapeutic agent delivery with focused ultrasound and microbubbles

Targeted Delivery Of Gdnf Through The Blood-Brain Barrier By Mri-Guided Focused Ultrasound

Advancements in ultrasound-mediated drug delivery for central nervous system disorders

Ultrasound for the Brain: A Review of Physical and Engineering Principles, and Clinical Applications

Current and emerging brain applications of MR-guided focused ultrasound

Ultrasound-assisted brain delivery of nanomedicines for brain tumor therapy: advance and prospect

Influence of focused ultrasound on locoregional drug delivery to the brain: Potential implications for brain tumor therapy

“Focused Ultrasound-mediated Drug Delivery in Humans – a Path Towards Translation in Neurodegenerative Diseases”

Utilizing Multifaceted Approaches to Target Drug Delivery in the Brain: From Nanoparticles to Biological Therapies

Clinical Applications of Micro/Nanobubble Technology in Neurological Diseases